TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30817543

Group type: EXPERIMENTAL
Intervention: Alcohol (96%) solution
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Gentamicin (80 mg) solution
Number of subjects: 30

Group type: COMPARATOR
Intervention: Formalin solution
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (0.9%) solution
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cefazolin sodium (Cezol 1gr) solution
Number of subjects: 30
Study: 29664109

Group type: EXPERIMENTAL
Intervention: Forced fluid removal (using furosemide and/or continuous renal replacement therapy)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 23
Study: 26336807

Group type: EXPERIMENTAL
Intervention: Instrumental Reminiscence Intervention (IRI)
Number of subjects: 60
Study: 23988273

Group type: EXPERIMENTAL
Intervention: Citalopram and escitalopram (SSRIs) for 10 days
Number of subjects: 17
Study: 22624605

Group type: EXPERIMENTAL
Intervention: Active cathodal PPC stimulation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Active anodal PPC stimulation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cathodal stimulation
Number of subjects: 30
Study: 21612045

Group type: EXPERIMENTAL
Intervention: Prophylactic measures including oral cavity checkup, hygiene instruction, promotion of oral health, sealing of I permanent molar teeth
Number of subjects: 101
Study: 18755727

Group type: EXPERIMENTAL
Intervention: Midazolam (5-10 mg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Entonox
Number of subjects: 49
Study: 15926109

Group type: EXPERIMENTAL
Intervention: Aldosterone (3 microg/minute)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Canrenoate (400 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Canrenoate (400 mg) + Aldosterone (3 microg/minute)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 12576812

Group type: EXPERIMENTAL
Intervention: Neural network algorithm based on urine levels of nuclear matrix protein‐22, monocyte chemoattractant protein‐1 and urinary intercellular adhesion molecule-1
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Neural network algorithm
Number of subjects: 253

Group type: COMPARATOR
Intervention: Hematuria dipstick test
Number of subjects: 253

Group type: COMPARATOR
Intervention: Atypical cytology
Number of subjects: 253
Study: 10549685

Group type: EXPERIMENTAL
Intervention: Carbamazepine (300 mg/day)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 8784742

Group type: EXPERIMENTAL
Intervention: Formula with 0.10% 22:6n‐3
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Formula with 0.11% 22:6n‐3
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Formula with 0.22% 22:6n‐3
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Formula with 0.24% 22:6n‐3
Number of subjects: 16

Group type: COMPARATOR
Intervention: Formula without 22:6n‐3
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Formula with 20% 18:2n‐6 and 2.4% 18:3n‐3
Number of subjects: 16

Group type: COMPARATOR
Intervention: Breast-fed infants
Number of subjects: 16
Study: 1899350

Group type: EXPERIMENTAL
Intervention: misoprostol (600 micrograms daily) with diclofenac (150 mg daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo with diclofenac (150 mg daily)
Number of subjects: 24
Study: 6347119

Group type: EXPERIMENTAL
Intervention: Low-dose fluphenazine decanoate (1.25 to 5.0 mg/2 wk)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Standard-dose fluphenazine decanoate (12.5 to 50.0 mg/2 wk)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Low-dose fluphenazine decanoate
Number of subjects: 126
Study: 31828896

Group type: EXPERIMENTAL
Intervention: Trials studying devices with humanitarian device exemption (HDE)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Trials studying devices with experimental indications (EI)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Trials of FDA-approved devices
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Overall trial quality
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Funding source
Number of subjects: 48
Study: 30107814

Group type: EXPERIMENTAL
Intervention: Usual education plus an additional module on realistic expectations for long-term recovery (intervention group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual pre-operative education (control group)
Number of subjects: 0
Study: 27084853

Group type: EXPERIMENTAL
Intervention: Online decision aid providing general and test-specific information on cholesterol and diabetes self-testing.
Number of subjects: 1259

Group type: COMPARATOR
Intervention: Limited information sheet (control condition).
Number of subjects: 1259
Study: 24168874

Group type: EXPERIMENTAL
Intervention: Meat group (githeri with meat)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Milk group (githeri plus whole milk)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Plain Githeri (githeri with added oil)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no intervention feeding)
Number of subjects: 12
Study: 23088297

Group type: EXPERIMENTAL
Intervention: High fiber whole grain rye bread (RB)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Refined wheat bread (WB)
Number of subjects: 33
Study: 20558037

Group type: EXPERIMENTAL
Intervention: Composite score from cardiovascular therapy trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Binary composite measure from cardiovascular therapy trial
Number of subjects: 0
Study: 17131168

Group type: EXPERIMENTAL
Intervention: Water perfusion catheter
Number of subjects: 18

Group type: COMPARATOR
Intervention: Microtip transducer catheter
Number of subjects: 18
Study: 15962224

Group type: EXPERIMENTAL
Intervention: 4-drug antiretroviral regimen
Number of subjects: 175
Study: 12870834

Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry powder inhaler (MF DPI) 400 microg twice daily
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry powder inhaler (MF DPI) 800 microg twice daily
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Mometasone furoate dry powder inhaler (MF DPI)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 10229468

Group type: EXPERIMENTAL
Intervention: Percutaneous gastrojejunostomy (PGJ)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Percutaneous endoscopic gastrostomy (PEG)
Number of subjects: 135
Study: 8966391

Group type: COMPARATOR
Intervention: Busulfan
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Alfa-interferon plus busulfan
Number of subjects: 30
Study: 1714697

Group type: EXPERIMENTAL
Intervention: Cow's milk infant formula with 40 mg Fe/100 g
Number of subjects: 149

Group type: COMPARATOR
Intervention: Cow's milk infant formula with 8.3 mg Fe/100 g
Number of subjects: 149
Study: 6667621

Group type: EXPERIMENTAL
Intervention: Progestasert IUD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiload Cu 250 IUD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparoscopic sterilization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 31688194

Group type: EXPERIMENTAL
Intervention: Online virtual mechanical ventilation simulator before clinical rotation
Number of subjects: 483

Group type: EXPERIMENTAL
Intervention: Online virtual mechanical ventilation simulator after clinical rotation
Number of subjects: 483

Group type: COMPARATOR
Intervention: Clinical rotation
Number of subjects: 483

Group type: EXPERIMENTAL
Intervention: Online intervention
Number of subjects: 483
Study: 29396217

Group type: EXPERIMENTAL
Intervention: Sanitation
Number of subjects: 5551

Group type: EXPERIMENTAL
Intervention: Handwashing
Number of subjects: 5551

Group type: EXPERIMENTAL
Intervention: Combined water, sanitation, and handwashing
Number of subjects: 5551

Group type: EXPERIMENTAL
Intervention: Nutrition
Number of subjects: 5551

Group type: EXPERIMENTAL
Intervention: Combined water, sanitation, handwashing, and nutrition
Number of subjects: 5551

Group type: EXPERIMENTAL
Intervention: Water treatment
Number of subjects: 5551

Group type: COMPARATOR
Intervention: Control
Number of subjects: 5551

Group type: EXPERIMENTAL
Intervention: Water, sanitation, and handwashing
Number of subjects: 5551
Study: 26743348

Group type: EXPERIMENTAL
Intervention: Atorvastatin reload (AR) 80 mg 12 hours before + 40 mg 2 hours before PCI
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Atorvastatin reload (AR)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 53
Study: 25713015

Group type: EXPERIMENTAL
Intervention: Patient controlled remifentanil
Number of subjects: 1414

Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 1414

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 1414
Study: 23702720

Group type: EXPERIMENTAL
Intervention: Focused rigidity casts (FRCs)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (canvas shoe)
Number of subjects: 31
Study: 20558006

Group type: EXPERIMENTAL
Intervention: Prednisolone (5 mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Prednisolone (5 mg and 10 mg)
Number of subjects: 28
Study: 18644681

Group type: EXPERIMENTAL
Intervention: Behavioral self-help program for smoking cessation
Number of subjects: 200
Study: 18089905

Group type: EXPERIMENTAL
Intervention: Caffeinated drink (5 mg/kg)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 14551176

Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Oral prednisolone
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 10925490

Group type: EXPERIMENTAL
Intervention: Ultracision
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional hemostasis
Number of subjects: 34
Study: 8648202

Group type: EXPERIMENTAL
Intervention: ca A/Los Angeles/2/87 (H3N2) vaccine
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: bivalent ca vaccine
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: monovalent ca H1N1 vaccine
Number of subjects: 182

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 182
Study: 1378690

Group type: EXPERIMENTAL
Intervention: Iloprost (i.v.) given for 14-28 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6652008

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Nefopam
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 37

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 37
Study: 31638498

Group type: EXPERIMENTAL
Intervention: Lower protein content formula during the 1st year of life
Number of subjects: 0

Group type: COMPARATOR
Intervention: Higher protein content formula during the 1st year of life
Number of subjects: 0
Study: 30092876

Group type: EXPERIMENTAL
Intervention: LF-LAM
Number of subjects: 1307
Study: 26666688

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy‐guided self‐help manual
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard support (control)
Number of subjects: 54
Study: 25133164

Group type: EXPERIMENTAL
Intervention: Green coffee (GC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Black coffee (BC)
Number of subjects: 0
Study: 22417778

Group type: EXPERIMENTAL
Intervention: Bacteroides xylanisolvens DSM 23964 (8.5×10^11 cells) in pasteurised fermented milk for 3 weeks
Number of subjects: 181

Group type: COMPARATOR
Intervention: Bacteroides xylanisolvens DSM 23964 (10^12 cells) in spray-dried fermented milk for 6 weeks
Number of subjects: 181
Study: 19959734

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo alcohol (Control)
Number of subjects: 12
Study: 17049883

Group type: EXPERIMENTAL
Intervention: Experimental investigation of perceptual experience after stroke
Number of subjects: 1
Study: 15024563

Group type: EXPERIMENTAL
Intervention: 3 ml (15 mg) 0.5% hyperbaric bupivacaine (bilateral group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: 1.5 ml (7.5 mg) 0.5% hyperbaric bupivacaine (unilateral group)
Number of subjects: 70
Study: 12350190

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care program (n = 447)
Number of subjects: 1113

Group type: COMPARATOR
Intervention: Usual care group (n = 303)
Number of subjects: 1113

Group type: COMPARATOR
Intervention: PEFR monitoring control group (n = 363)
Number of subjects: 1113
Study: 9843464

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 40895

Group type: EXPERIMENTAL
Intervention: Sustained VT/VF
Number of subjects: 40895

Group type: EXPERIMENTAL
Intervention: Sustained VT and VF
Number of subjects: 40895

Group type: COMPARATOR
Intervention: Surviving hospitalization
Number of subjects: 40895
Study: 8080374

Group type: EXPERIMENTAL
Intervention: Isolated bypass to the superior mesenteric artery (SMA)
Number of subjects: 26
Study: 2511696

Group type: EXPERIMENTAL
Intervention: pentaerythrityltetranitrate (PETN) 50-300 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: isosorbide dinitrate (ISDN) 40-120 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: sublingual nitroglycerin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: long-acting nitrates (PETN and ISDN)
Number of subjects: 24
Study: 981634

Group type: EXPERIMENTAL
Intervention: Large daily fractions of 400 rads/day for 10-12 treatments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional fractionation schedules using 200 rads/day
Number of subjects: 0
Study: 31123053

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel pharmacologic therapeutics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 28215827

Group type: EXPERIMENTAL
Intervention: Goal setting and decision support intervention (16-week program with one in-person session and seven biweekly telephone coaching calls)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (information about local health care resources on the same contact schedule)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 54
Study: 25886178

Group type: EXPERIMENTAL
Intervention: Personalised Feedback and Brief Advice (PFBA)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Personalised Feedback plus electronic Brief Intervention (eBI)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Screening alone (Control)
Number of subjects: 1500
Study: 24083440

Group type: EXPERIMENTAL
Intervention: Brain MRI to determine the presence of brain infarcts and other cerebrovascular lesions (brain microbleeds, white matter changes, enlarged perivascular spaces)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Assessment of other organ damage (heart-left ventricular hypertrophy, kidney-urine albumin to creatinine ratio, vessels-pulse wave velocity, ankle brachial index)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Follow-up for at least 3 years
Number of subjects: 1000
Study: 20966122

Group type: EXPERIMENTAL
Intervention: Enalapril + Losartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enalapril + Placebo
Number of subjects: 0
Study: 19565422

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system (LNG-IUS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Depot-medroxyprogesterone acetate (DMPA)
Number of subjects: 50
Study: 17103417

Group type: COMPARATOR
Intervention: Placebo response (PRs)
Number of subjects: 451

Group type: COMPARATOR
Intervention: Follow-up of placebo responders (PRs)
Number of subjects: 451

Group type: COMPARATOR
Intervention: Nonresponders (NRs)
Number of subjects: 451
Study: 14766942

Group type: EXPERIMENTAL
Intervention: Downhill running (8 deg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Downhill running (4 deg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Uphill running (4 deg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study: 11551733

Group type: EXPERIMENTAL
Intervention: 6-session CBT program (6CBT)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: 1-session CBT intervention (1CBT)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Delayed-treatment control (DTC)
Number of subjects: 229
Study: 9704701

Group type: EXPERIMENTAL
Intervention: Prolonged heparin infusion after PTCA
Number of subjects: 191

Group type: COMPARATOR
Intervention: No postprocedure heparin (control group)
Number of subjects: 191
Study: 7991318

Group type: EXPERIMENTAL
Intervention: Survey of stress experienced while officiating
Number of subjects: 782
Study: 2656766

Group type: EXPERIMENTAL
Intervention: Amine fluoride-stannous fluoride mouthrinse
Number of subjects: 16

Group type: COMPARATOR
Intervention: Chlorhexidine mouthrinse
Number of subjects: 16
Study: 29135600

Group type: EXPERIMENTAL
Intervention: Tai Chi training program (16 weeks)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no Tai Chi training)
Number of subjects: 29
Study: 28489637

Group type: EXPERIMENTAL
Intervention: Open tracheal suctioning
Number of subjects: 24

Group type: COMPARATOR
Intervention: Closed tracheal suctioning
Number of subjects: 24
Study: 25491493

Group type: EXPERIMENTAL
Intervention: Eluxadoline (200 mg dose) coadministered with cyclosporine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eluxadoline (200 mg dose) coadministered with probenecid
Number of subjects: 0
Study: 22777107

Group type: EXPERIMENTAL
Intervention: Skimmed milk drinking yogurts enriched with phytosteryl/‐stanyl fatty acid esters
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Skimmed milk drinking yogurts enriched with ferulates
Number of subjects: 0
Study: 20798655

Group type: EXPERIMENTAL
Intervention: 1000 mg of calcium 20 min before exercise
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 250 mg of calcium every 15 min during exercise (1000 mg total)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo before and during exercise
Number of subjects: 20
Study: 19244379

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) intake
Number of subjects: 0
Study: 16420509

Group type: EXPERIMENTAL
Intervention: 20% human albumin
Number of subjects: 68

Group type: COMPARATOR
Intervention: 3.5% polygeline (synthetic colloid)
Number of subjects: 68
Study: 12956861

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulins (IgG) at doses of 1, 5, and 10 mg/ml
Number of subjects: 25
Study: 12058972

Group type: EXPERIMENTAL
Intervention: Conflict resolution and peer mediation training integrated into social studies curriculum for 5 weeks (105 min every other day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group studying the same social studies curriculum without conflict resolution and peer mediation training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conflict resolution and peer mediation training integrated into social studies curriculum
Number of subjects: 0
Study: 9717348

Group type: EXPERIMENTAL
Intervention: Health Education (HE) monitored with group session and postal back-up
Number of subjects: 110

Group type: COMPARATOR
Intervention: Health Education (HE) from family doctor
Number of subjects: 110
Study: 7644452

Group type: EXPERIMENTAL
Intervention: Community-wide quit-smoking contests
Number of subjects: 11
Study: 2707117

Group type: EXPERIMENTAL
Intervention: 28 g sucrose during a mixed meal (meal A)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saccharin during a mixed meal (meal B)
Number of subjects: 6
Study: 367726

Group type: EXPERIMENTAL
Intervention: S‐carboxymethylcysteine (2 grams)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 30604663

Group type: COMPARATOR
Intervention: Active Control (non‐nutrition, ‐physical activity (PA), ‐mental health)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Standard Care (nutrition and PA)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Enhanced Care (nutrition and PA, plus cognitive behavioural techniques)
Number of subjects: 87
Study: 29116298

Group type: EXPERIMENTAL
Intervention: 4% titanium tetrafluoride (TiF 4) varnish
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 5% sodium fluoride (NaF) varnish
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo varnish
Number of subjects: 12

Group type: COMPARATOR
Intervention: Negative control (deionized water)
Number of subjects: 12
Study: 25293368

Group type: EXPERIMENTAL
Intervention: AS03B-adjuvanted H5N1 influenza vaccine (1.9 µg of hemagglutinin and 5.93 mg of α-tocopherol)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AS03B-adjuvanted H5N1 influenza vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23504641

Group type: EXPERIMENTAL
Intervention: Homework compliance quality
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Exposure homework
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Homework relating to psychoeducation and self‐monitoring
Number of subjects: 292
Study: 21730902

Group type: EXPERIMENTAL
Intervention: Premature Infant Oral Motor Intervention (PIOMI) for 5 minutes per day for 7 consecutive days
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham intervention (control group)
Number of subjects: 19
Study: 19589539

Group type: EXPERIMENTAL
Intervention: Iloprost (3000 ng intra-arterial bolus over 1 to 3 min immediately after revascularization)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 16364360

Group type: EXPERIMENTAL
Intervention: Vowel context usage when spelling word-final consonants (codas)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vowel context usage when spelling word-initial consonants (onsets)
Number of subjects: 0
Study: 14702450

Group type: EXPERIMENTAL
Intervention: Educational intervention (10-minute training session and handout on using a pediatric digital library)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups used computers and digital libraries to answer questions
Number of subjects: 52
Study: 12575371

Group type: EXPERIMENTAL
Intervention: Xuelong Granule (XLG)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Shenchai Granule
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Xuelong Granule (XLG) in experimental study on model rats
Number of subjects: 98